Nonstereotyped Lymphoma B Cell Receptors Recognize Vimentin as a Shared Autoantigen
暂无分享,去创建一个
Jinsong Wei | L. Kwak | S. Neelapu | R. Davis | A. Luong | F. Baio | H. Qin | Weiguo Wu | S. Rawal | S. Cha | Kunhwa Kim | S. Kannan | H. Schroeder | Leticia S. Watkins | Juliana Ong | Benjamin Kwak | Michael S. Popescu | Daniel S. Paick | Sang Kim
[1] Ash A. Alizadeh,et al. Self-antigen recognition by follicular lymphoma B-cell receptors. , 2012, Blood.
[2] G. Hughes,et al. Vimentin/cardiolipin complex as a new antigenic target of the antiphospholipid syndrome. , 2010, Blood.
[3] Ash A. Alizadeh,et al. B-cell signaling networks reveal a negative prognostic human lymphoma cell subset that emerges during tumor progression , 2010, Proceedings of the National Academy of Sciences.
[4] J. Winter,et al. Placebo-controlled phase III trial of patient-specific immunotherapy with mitumprotimut-T and granulocyte-macrophage colony-stimulating factor after rituximab in patients with follicular lymphoma. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[5] Xiao-Jie Yan,et al. From bloodjournal.hematologylibrary.org at PENN STATE UNIVERSITY on February 21, 2013. For personal use only. , 2007 .
[6] N. Rawal,et al. Vimentin expressed on Mycobacterium tuberculosis-infected human monocytes is involved in binding to the NKp46 receptor , 2008, The Journal of Immunology.
[7] L. Dölken,et al. Age-dependent prevalence and frequency of circulating t(14;18)-positive cells in the peripheral blood of healthy individuals. , 2008, Journal of the National Cancer Institute. Monographs.
[8] R. Rosenquist,et al. A new perspective: molecular motifs on oxidized LDL, apoptotic cells, and bacteria are targets for chronic lymphocytic leukemia antibodies. , 2008, Blood.
[9] T. Podor,et al. Vimentin autoantibodies induce platelet activation and formation of platelet‐leukocyte conjugates via platelet‐activating factor , 2008, Journal of leukocyte biology.
[10] N. Marceau,et al. Dual roles of intermediate filaments in apoptosis. , 2007, Experimental cell research.
[11] M. Nussenzweig,et al. Autoreactivity in human IgG+ memory B cells. , 2007, Immunity.
[12] Jonathan M Irish,et al. Altered B-cell receptor signaling kinetics distinguish human follicular lymphoma B cells from tumor-infiltrating nonmalignant B cells. , 2006, Blood.
[13] B. Nadel,et al. Follicular lymphoma-like B cells in healthy individuals: a novel intermediate step in early lymphomagenesis , 2006, The Journal of experimental medicine.
[14] J. Leonard,et al. Phase II trial of idiotype vaccination in previously treated patients with indolent non-Hodgkin's lymphoma resulting in durable clinical responses. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[15] D. Stevens,et al. Group A streptococcal myonecrosis: increased vimentin expression after skeletal-muscle injury mediates the binding of Streptococcus pyogenes. , 2006, The Journal of infectious diseases.
[16] D. Girard,et al. Cell surface expression of intermediate filament proteins vimentin and lamin B1 in human neutrophil spontaneous apoptosis , 2006, Journal of leukocyte biology.
[17] M. Nussenzweig,et al. A checkpoint for autoreactivity in human IgM+ memory B cell development , 2006, The Journal of experimental medicine.
[18] P. Ferrara,et al. SC5 mAb Represents a Unique Tool for the Detection of Extracellular Vimentin as a Specific Marker of Sézary Cells1 , 2006, The Journal of Immunology.
[19] Craig W. Reynolds,et al. Vaccine-induced tumor-specific immunity despite severe B-cell depletion in mantle cell lymphoma , 2005, Nature Medicine.
[20] Fran Lewitter,et al. Intragenic tandem repeats generate functional variability , 2005, Nature Genetics.
[21] B. Barlogie,et al. Tumor antigen immunization of sibling stem cell transplant donors in multiple myeloma , 2005, Bone Marrow Transplantation.
[22] R. Schelonka,et al. Development of the Expressed Ig CDR-H3 Repertoire Is Marked by Focusing of Constraints in Length, Amino Acid Use, and Charge That Are First Established in Early B Cell Progenitors1 , 2005, The Journal of Immunology.
[23] E. Meffre,et al. Unmutated and mutated chronic lymphocytic leukemias derive from self-reactive B cell precursors despite expressing different antibody reactivity. , 2005, The Journal of clinical investigation.
[24] D. de Jong,et al. Among B cell non-Hodgkin's lymphomas, MALT lymphomas express a unique antibody repertoire with frequent rheumatoid factor reactivity , 2005, The Journal of experimental medicine.
[25] Ralf Küppers,et al. Mechanisms of B-cell lymphoma pathogenesis , 2005, Nature Reviews Cancer.
[26] M. C. Popescu,et al. Human Autologous Tumor-Specific T-Cell Responses Induced by Liposomal Delivery of a Lymphoma Antigen , 2004, Clinical Cancer Research.
[27] W. Vanvenrooij,et al. Autoantibodies to citrullinated proteins in rheumatoid arthritis: clinical performance and biochemical aspects of an RA-specific marker. , 2004, Clinica chimica acta; international journal of clinical chemistry.
[28] D. Markovitz,et al. The Endothelial Cell-Specific Antibody PAL-E Identifies a Secreted Form of Vimentin in the Blood Vasculature , 2004, Molecular and Cellular Biology.
[29] Marie-Paule Lefranc,et al. IMGT/V-QUEST, an integrated software program for immunoglobulin and T cell receptor VJ and VDJrearrangement analysis , 2004, Nucleic Acids Res..
[30] Anna Tramontano,et al. Remarkably similar antigen receptors among a subset of patients with chronic lymphocytic leukemia. , 2004, The Journal of clinical investigation.
[31] C. Huff,et al. Characterization of clonogenic multiple myeloma cells. , 2004, Blood.
[32] J. Engler,et al. Expressed murine and human CDR-H3 intervals of equal length exhibit distinct repertoires that differ in their amino acid composition and predicted range of structures. , 2003, Journal of molecular biology.
[33] M. Nussenzweig,et al. Predominant Autoantibody Production by Early Human B Cell Precursors , 2003, Science.
[34] T. Hamblin,et al. Acquisition of potential N-glycosylation sites in the immunoglobulin variable region by somatic mutation is a distinctive feature of follicular lymphoma. , 2002, Blood.
[35] R. Bende,et al. Variable heavy chain gene analysis of follicular lymphomas: correlation between heavy chain isotype expression and somatic mutation load. , 2000, Blood.
[36] Craig W. Reynolds,et al. Complete molecular remissions induced by patient-specific vaccination plus granulocyte–monocyte colony-stimulating factor against lymphoma , 1999, Nature Medicine.
[37] D. Jong,et al. Lymphoma-associated translocation t(14;18) in blood B cells of normal individuals. , 1995, Blood.
[38] H Stein,et al. A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. , 1994, Blood.
[39] D. Bahler,et al. Clonal evolution of a follicular lymphoma: evidence for antigen selection. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[40] R. Miller,et al. Autoantibody activity of immunoglobulins isolated from B-cell follicular lymphomas. , 1991, Blood.
[41] T. McDonnell,et al. Progression from lymphoid hyperplasia to high-grade malignant lymphoma in mice transgenic for the t(14;18) , 1991, Nature.
[42] P. Youinou,et al. Relation of antivimentin antibodies to anticardiolipin antibodies in systemic lupus erythematosus. , 1988, Annals of the rheumatic diseases.
[43] W. Carroll,et al. Mouse x human heterohybridomas as fusion partners with human B cell tumors. , 1986, Journal of immunological methods.
[44] C. Croce,et al. The t(14;18) chromosome translocations involved in B-cell neoplasms result from mistakes in VDJ joining. , 1985, Science.
[45] Y. Tsujimoto,et al. Involvement of the bcl-2 gene in human follicular lymphoma. , 1985, Science.
[46] R. Doolittle,et al. A simple method for displaying the hydropathic character of a protein. , 1982, Journal of molecular biology.
[47] R. Bende,et al. Molecular pathways in follicular lymphoma , 2007, Leukemia.
[48] D. Markovitz,et al. Vimentin is secreted by activated macrophages , 2003, Nature Cell Biology.
[49] D. Eisenberg. Three-dimensional structure of membrane and surface proteins. , 1984, Annual review of biochemistry.